A high throughput screening assay for human Thyroperoxidase inhibitors
Resources
3 resources available
-
1-s2.0-S0887233324001760-Supplement1.docx
APPLICATION/VND.OPENXMLFORMATS-OFFICEDOCUMENT.WORDPROCESSINGML.DOCUMENT -
1-s2.0-S0887233324001760-Supplement2.pdf
APPLICATION/PDF -
1-s2.0-S0887233324001760-Supplement3.xlsx
APPLICATION/VND.OPENXMLFORMATS-OFFICEDOCUMENT.SPREADSHEETML.SHEET
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[ "020:00" ] |
| contactPoint |
{ "fn": "Katie Friedman", "hasEmail": "mailto:paul-friedman.katie@epa.gov" } |
| description | Dataset for 'A high throughput screening assay for human Thyroperoxidase inhibitors' by Hongyan Dong, et al., a collaboration work with primary authorship at Health Canada. Published in Toxicology in Vitro, Vol 101, 105946, Dec 2024; DOI https://doi.org/10.1016/j.tiv.2024.105946. Supplementary Data File 1: Examples of two solution plates and the resulting assay plate layouts for Single concentration phase. Supplementary Data File 2: The tcpl analyses of all multiple concentration phase data including plots of fitted models, estimates of log AC50 (ga), and hit call. Supplementary Data File 3: Supplementary Tables 1-5. For further data, please contact corresponding author Hongyan Dong at email Hongyan.Dong@hc-sc.gc.ca. This dataset is associated with the following publication: Dong, H., K. Friedman, A. Filiatreault, E. Thomson, and M. Wade. A high throughput screening assay for human Thyroperoxidase inhibitors. TOXICOLOGY IN VITRO. Elsevier Science Ltd, New York, NY, USA, 101: 105946, (2024). |
| distribution |
[ { "title": "1-s2.0-S0887233324001760-Supplement1.docx", "mediaType": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "downloadURL": "https://pasteur.epa.gov/uploads/10.23719/1532100/1-s2.0-S0887233324001760-Supplement1.docx" }, { "title": "1-s2.0-S0887233324001760-Supplement2.pdf", "mediaType": "application/pdf", "downloadURL": "https://pasteur.epa.gov/uploads/10.23719/1532100/1-s2.0-S0887233324001760-Supplement2.pdf" }, { "title": "1-s2.0-S0887233324001760-Supplement3.xlsx", "mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet", "downloadURL": "https://pasteur.epa.gov/uploads/10.23719/1532100/1-s2.0-S0887233324001760-Supplement3.xlsx" } ] |
| identifier | https://doi.org/10.23719/1532100 |
| keyword |
[ "Screening assay", "Thyroid peroxidase", "endocrine disruption", "thyroid hormone" ] |
| license | https://pasteur.epa.gov/license/sciencehub-license-non-epa-generated.html |
| modified | 2024-07-16 |
| programCode |
[ "020:000" ] |
| publisher |
{ "name": "U.S. EPA Office of Research and Development (ORD)", "subOrganizationOf": { "name": "U.S. Environmental Protection Agency", "subOrganizationOf": { "name": "U.S. Government" } } } |
| references |
[ "https://doi.org/10.1016/j.tiv.2024.105946" ] |
| rights |
null
|
| title | A high throughput screening assay for human Thyroperoxidase inhibitors |